Cytokinetics
CYTK
109 hedge funds and large institutions have $187M invested in Cytokinetics in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 31 closing their positions.
257% more call options, than puts
Call options by funds: $4.27M | Put options by funds: $1.2M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less funds holding
Funds holding: 125 → 109 (-16)
23% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 39
32% less capital invested
Capital invested by funds: $276M → $187M (-$89.1M)
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$10.4M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.63M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
Top Sellers
| 1 |
TA
Teachers Advisors
New York
|
-$4.02M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.95M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.65M |
| 4 |
Renaissance Technologies
New York
|
-$2.45M |
| 5 |
Millennium Management
New York
|
-$2.03M |
CYTK Hedge Fund Activity: Q1 2016 in Review
109 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2016, worth a combined $187M — down 32% from $276M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CYTK and 15 opened new positions — a net loss of 16 holders — while 39 trimmed existing stakes and 30 added.
The largest buyer was Wellington Management Group, adding an estimated $12.2M. The largest seller was Teachers Advisors, cutting an estimated $4.02M.
- 109 institutional investors held Cytokinetics (CYTK) as of Q1 2016, down from 125 in Q4 2015.
- Funds reported $187M of Cytokinetics stock for Q1 2016, down 32% quarter-over-quarter.
- 15 funds opened new Cytokinetics positions in Q1 2016 and 31 closed out, a net change of -16 holders.
- The largest Cytokinetics buyer in Q1 2016 was Wellington Management Group, an estimated $12.2M added.
- The largest Cytokinetics seller in Q1 2016 was Teachers Advisors, an estimated $4.02M sold.
Based on aggregated 13F filings for Q1 2016.